The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life and lifestyle changes during and after therapy in women with endometrial cancer: A global study of 1,066 patients (NOGGO, ENGOT, GCIG, ENGAGe-IMPROVE/EXPRESSION XI).
 
Lukas Chinczewski
Honoraria - Eisai; GlaxoSmithKline; NOGGO e.V.
Consulting or Advisory Role - Myriad Genetics
Research Funding - GlaxoSmithKline (Inst)
 
Jean Emmanuel Kurtz
Employment - MSD (I)
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; MSD
Travel, Accommodations, Expenses - AstraZeneca; Eisai; GlaxoSmithKline
 
Flurina Saner
No Relationships to Disclose
 
Maja Krajewska
No Relationships to Disclose
 
Katharina Leitner
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD
 
Maria-Pilar Barretina-Ginesta
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai Europe; GlaxoSmithKline; MSD Oncology; Pharma&; PharmaMar; Regeneron
Speakers' Bureau - Abbvie; AstraZeneca Spain; Eisai Europe; GlaxoSmithKline; MSD Oncology; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology
 
Dana Stanculeanu
No Relationships to Disclose
 
Michal Zikan
No Relationships to Disclose
 
Jonathan Berek
Research Funding - Eisai (Inst); ImmunoGen (Inst); Karyoharm (Inst); Merck (Inst)
 
Hans-Martin Enzinger
No Relationships to Disclose
 
Dominique Berton
No Relationships to Disclose
 
Claudia Mang
No Relationships to Disclose
 
Theresa Bernard
No Relationships to Disclose
 
Julie Leseur
No Relationships to Disclose
 
Tibor Zwimpfer
Consulting or Advisory Role - Abbvie
 
Anna-Lisa Spranger
Honoraria - Novartis
 
Christin Traut
No Relationships to Disclose
 
Hannelore Denys
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Seagen (Inst); Teva (Inst)
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Teva (Inst)
 
Malgorzata Kretowska
Travel, Accommodations, Expenses - AstraZeneca
 
Jalid Sehouli
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Clovis Oncology; Corcept Therapeutics; Daiichi; Eisai; Esteve Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; Hexal; Incyte; Jenapharm; Johnson & Johnson; Kyowa Kirin International; Medtronic Covidien; MSD Oncology; Myriad Pharmaceuticals; Novartis; Oncoinvent; Pfizer; PharmaMar; Phytolife Nutrition; Roche; Vifor Pharma
Consulting or Advisory Role - Alkermes; AstraZeneca; Bayer/Vital; Bristol Myers Squibb; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo; Eisai; GlaxoSmithKline; Immunogen; Ingress Health; Intuitive Surgical; Johnson & Johnson; Karyopharm Therapeutics; Lilly; Merck; MSD Oncology; Mundipharma; Novocure; Oncoinvent; Pfizer; PharmaMar; Roche; Sanofi Aventis GmbH; Seagen; Sobi; Tubulis GmbH
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); IQvia (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); MSD Oncology (Inst); Mural (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG